Iquix FDA Approval History
FDA Approved: Yes (Discontinued) (First approved March 1, 2004)
Brand name: Iquix
Generic name: levofloxacin ophthalmic
Dosage form: Ophthalmic Solution
Treatment for: Corneal Ulcer
Marketing Status: Discontinued
Iquix (levofloxacin) is a topical fluoroquinolone indicated for the treatment of bacterial corneal ulcers.
Development timeline for Iquix
|Mar 1, 2004||Approval Iquix Santen - Treatment for Bacterial Corneal Ulcers|
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.